Big Pharma's patent cliffs are forcing acquirers to hunt for revenue-producing biotech assets before rivals snap them up, and ...

Anthropic AI for Science event livestreams today as the company pitches Claude to pharma and biotech leaders. The session ...

Nebraska shows how America’s Heartland can power U.S. bioeconomy leadership by linking innovation in agriculture, research, ...

These 8 healthcare stocks delivered strong gains last week. Discover what drove each rally—and why not all rallies are ...

Apogee Therapeutics — The biotechnology company soared 50% after AbbVie confirmed it will acquire the company. The $10.9 ...

Scientists pieced together the genetic history of Acinetobacter baumannii — a notoriously stubborn hospital pathogen — using ...

This statistical finding supports a lower liver-weight signal after adjustment for body fat percentage, suggesting the finding was not fully explained by measured body fat in this modelLiver-weight ...

A former executive at the buyout firm told his lawyer of alleged alcohol and drug-fuelled parties and said one of its businesses was a “drug-fuelled pit”.

While investors are focused on AI and Big Tech, Bank of America says they should also be looking at the mid-cap segment for ...

Add Yahoo as a preferred source to see more of our stories on Google. A little-noticed provision in next year’s defense bill has united an unusual coalition of progressive Democrats and conservatives, ...

New research at Carilion Clinic and Virginia Tech’s Fralin Biomedical Research Institute at VTC is positioning Southwest ...

AI-powered diagnostics meet global oncology innovation as two medical disruptors post strong revenue growth, yet face distinct risk and valuation profiles.